Copyright Reports & Markets. All rights reserved.

Global Omeprazole Market Research Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Omeprazole Market Overview

      • 1.1 Product Overview and Scope of Omeprazole
      • 1.2 Omeprazole Segment by Type
        • 1.2.1 Global Omeprazole Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Capsule
        • 1.2.3 Tablet
        • 1.2.4 Injection
      • 1.3 Omeprazole Segment by Application
        • 1.3.1 Omeprazole Consumption Comparison by Application (2014-2025)
        • 1.3.2 Children
        • 1.3.3 Adult
      • 1.3 Global Omeprazole Market by Region
        • 1.3.1 Global Omeprazole Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Omeprazole Market Size
        • 1.4.1 Global Omeprazole Revenue (2014-2025)
        • 1.4.2 Global Omeprazole Production (2014-2025)

      2 Global Omeprazole Market Competition by Manufacturers

      • 2.1 Global Omeprazole Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Omeprazole Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Omeprazole Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Omeprazole Production Sites, Area Served, Product Types
      • 2.5 Omeprazole Market Competitive Situation and Trends
        • 2.5.1 Omeprazole Market Concentration Rate
        • 2.5.2 Omeprazole Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Omeprazole Production Market Share by Regions

      • 3.1 Global Omeprazole Production Market Share by Regions
      • 3.2 Global Omeprazole Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Omeprazole Production
        • 3.4.1 North America Omeprazole Production Growth Rate (2014-2019)
        • 3.4.2 North America Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Omeprazole Production
        • 3.5.1 Europe Omeprazole Production Growth Rate (2014-2019)
        • 3.5.2 Europe Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Omeprazole Production (2014-2019)
        • 3.6.1 China Omeprazole Production Growth Rate (2014-2019)
        • 3.6.2 China Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Omeprazole Production (2014-2019)
        • 3.7.1 Japan Omeprazole Production Growth Rate (2014-2019)
        • 3.7.2 Japan Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Omeprazole Consumption by Regions

      • 4.1 Global Omeprazole Consumption by Regions
      • 4.2 North America Omeprazole Consumption (2014-2019)
      • 4.3 Europe Omeprazole Consumption (2014-2019)
      • 4.4 China Omeprazole Consumption (2014-2019)
      • 4.5 Japan Omeprazole Consumption (2014-2019)

      5 Global Omeprazole Production, Revenue, Price Trend by Type

      • 5.1 Global Omeprazole Production Market Share by Type (2014-2019)
      • 5.2 Global Omeprazole Revenue Market Share by Type (2014-2019)
      • 5.3 Global Omeprazole Price by Type (2014-2019)
      • 5.4 Global Omeprazole Production Growth by Type (2014-2019)

      6 Global Omeprazole Market Analysis by Applications

      • 6.1 Global Omeprazole Consumption Market Share by Application (2014-2019)
      • 6.2 Global Omeprazole Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Omeprazole Business

      • 7.1 AstraZeneca AB
        • 7.1.1 AstraZeneca AB Omeprazole Production Sites and Area Served
        • 7.1.2 Omeprazole Product Introduction, Application and Specification
        • 7.1.3 AstraZeneca AB Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Sandoz
        • 7.2.1 Sandoz Omeprazole Production Sites and Area Served
        • 7.2.2 Omeprazole Product Introduction, Application and Specification
        • 7.2.3 Sandoz Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Actavis
        • 7.3.1 Actavis Omeprazole Production Sites and Area Served
        • 7.3.2 Omeprazole Product Introduction, Application and Specification
        • 7.3.3 Actavis Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Teva
        • 7.4.1 Teva Omeprazole Production Sites and Area Served
        • 7.4.2 Omeprazole Product Introduction, Application and Specification
        • 7.4.3 Teva Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Mylan
        • 7.5.1 Mylan Omeprazole Production Sites and Area Served
        • 7.5.2 Omeprazole Product Introduction, Application and Specification
        • 7.5.3 Mylan Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 KernPharm
        • 7.6.1 KernPharm Omeprazole Production Sites and Area Served
        • 7.6.2 Omeprazole Product Introduction, Application and Specification
        • 7.6.3 KernPharm Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Garmish Pharmaceuticals
        • 7.7.1 Garmish Pharmaceuticals Omeprazole Production Sites and Area Served
        • 7.7.2 Omeprazole Product Introduction, Application and Specification
        • 7.7.3 Garmish Pharmaceuticals Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Sanofi, Mepha
        • 7.8.1 Sanofi, Mepha Omeprazole Production Sites and Area Served
        • 7.8.2 Omeprazole Product Introduction, Application and Specification
        • 7.8.3 Sanofi, Mepha Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Saval Pharmaceutical
        • 7.9.1 Saval Pharmaceutical Omeprazole Production Sites and Area Served
        • 7.9.2 Omeprazole Product Introduction, Application and Specification
        • 7.9.3 Saval Pharmaceutical Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Stada
        • 7.10.1 Stada Omeprazole Production Sites and Area Served
        • 7.10.2 Omeprazole Product Introduction, Application and Specification
        • 7.10.3 Stada Omeprazole Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Blaskov
      • 7.12 CQ Lummy

      8 Omeprazole Manufacturing Cost Analysis

      • 8.1 Omeprazole Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Omeprazole
      • 8.4 Omeprazole Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Omeprazole Distributors List
      • 9.3 Omeprazole Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Omeprazole Market Forecast

      • 11.1 Global Omeprazole Production, Revenue Forecast
        • 11.1.1 Global Omeprazole Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Omeprazole Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Omeprazole Price and Trend Forecast (2019-2025)
      • 11.2 Global Omeprazole Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Omeprazole Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Omeprazole Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Omeprazole Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Omeprazole Production, Revenue Forecast (2019-2025)
      • 11.3 Global Omeprazole Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Omeprazole Consumption Forecast (2019-2025)
        • 11.3.2 Europe Omeprazole Consumption Forecast (2019-2025)
        • 11.3.3 China Omeprazole Consumption Forecast (2019-2025)
        • 11.3.4 Japan Omeprazole Consumption Forecast (2019-2025)
      • 11.4 Global Omeprazole Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Omeprazole Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Omeprazole market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Omeprazole volume and value at global level, regional level and company level. From a global perspective, this report represents overall Omeprazole market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        AstraZeneca AB
        Sandoz
        Actavis
        Teva
        Mylan
        KernPharm
        Garmish Pharmaceuticals
        Sanofi, Mepha
        Saval Pharmaceutical
        Stada
        Blaskov
        CQ Lummy

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Capsule
        Tablet
        Injection

        Segment by Application
        Children
        Adult

        Buy now